These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
667 related items for PubMed ID: 22027845
1. Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies. Weisler RH, Montgomery SA, Earley WR, Szamosi J, Lazarus A. Int Clin Psychopharmacol; 2012 Jan; 27(1):27-39. PubMed ID: 22027845 [Abstract] [Full Text] [Related]
2. Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled study. Merideth C, Cutler AJ, She F, Eriksson H. Int Clin Psychopharmacol; 2012 Jan; 27(1):40-54. PubMed ID: 22045039 [Abstract] [Full Text] [Related]
3. Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial. Liebowitz M, Lam RW, Lepola U, Datto C, Sweitzer D, Eriksson H. Depress Anxiety; 2010 Oct; 27(10):964-76. PubMed ID: 20734365 [Abstract] [Full Text] [Related]
4. Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder. Katila H, Mezhebovsky I, Mulroy A, Berggren L, Eriksson H, Earley W, Datto C. Am J Geriatr Psychiatry; 2013 Aug; 21(8):769-84. PubMed ID: 23567397 [Abstract] [Full Text] [Related]
5. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial. Cutler AJ, Datto C, Nordenhem A, Minkwitz M, Acevedo L, Darko D. Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797 [Abstract] [Full Text] [Related]
6. Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder: secondary analyses in subgroups of patients according to baseline anxiety, sleep disturbance, and pain levels. Montgomery SA, Altamura AC, Katila H, Datto C, Szamosi J, Eriksson H. Int Clin Psychopharmacol; 2014 Mar; 29(2):93-105. PubMed ID: 24162081 [Abstract] [Full Text] [Related]
7. Extended release quetiapine fumarate in major depressive disorder: analysis in patients with anxious depression. Thase ME, Demyttenaere K, Earley WR, Gustafsson U, Udd M, Eriksson H. Depress Anxiety; 2012 Jul; 29(7):574-86. PubMed ID: 22753280 [Abstract] [Full Text] [Related]
8. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study. El-Khalili N, Joyce M, Atkinson S, Buynak RJ, Datto C, Lindgren P, Eriksson H. Int J Neuropsychopharmacol; 2010 Aug; 13(7):917-32. PubMed ID: 20175941 [Abstract] [Full Text] [Related]
12. Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study. Bauer M, Pretorius HW, Constant EL, Earley WR, Szamosi J, Brecher M. J Clin Psychiatry; 2009 Apr; 70(4):540-9. PubMed ID: 19358791 [Abstract] [Full Text] [Related]
19. Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder. Mezhebovsky I, Mägi K, She F, Datto C, Eriksson H. Int J Geriatr Psychiatry; 2013 Jun; 28(6):615-25. PubMed ID: 23070803 [Abstract] [Full Text] [Related]
20. Extended release quetiapine fumarate in patients with major depressive disorder: suicidality data from acute and maintenance studies. Weisler R, Montgomery SA, Earley WR, Szamosi J, Eriksson H. J Clin Psychiatry; 2014 May; 75(5):520-7. PubMed ID: 24816198 [Abstract] [Full Text] [Related] Page: [Next] [New Search]